Syndax Pharmaceuticals, Inc. (SNDX)
19.63
-0.60
(-2.97%)
USD |
NASDAQ |
May 18, 13:08
Syndax Pharmaceuticals Profit Margin (Quarterly) : -65.79% for March 31, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | -- |
| Vera Therapeutics, Inc. | -- |
| Biogen, Inc. | 13.29% |
| Amgen, Inc. | 21.02% |
| Ardelyx, Inc. | -39.80% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -204.7% |
| Return on Assets | -43.58% |
| Return on Invested Capital | -52.39% |
| Gross Profit Margin (Quarterly) | 95.93% |
| Operating Margin (Quarterly) | -52.73% |
| Return on Net Operating Assets | -348.3% |